Because cancer cells with these genetic alterations in EGFR gene become highly dependent on the continuous activation of the EGFR pathway to establish and maintain their growth advantage, EGFR has been a key target of multiple cancer therapies in clinical practice. The gene discussed is EGFR; the disease is cancer.